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Inﬂammation Is Necessary for Long-Term but not
Short-Term HFD-Induced Insulin Resistance
Yun Sok Lee,1,2,3 Pingping Li,3 Jin Young Huh,1,2 In Jae Hwang,1,2 Min Lu,3 Jong In Kim,1,2
Mira Ham,1,2 Saswata Talukdar,3 Ai Chen,3 Wendell J. Lu,3 Guatam K. Bandyopadhyay,3
Reto Schwendener,4 Jerrold Olefsky,3 and Jae Bum Kim1,2,5
OBJECTIVE—Tissue inﬂammation is a key factor underlying in-
sulin resistance in established obesity. Several models of immuno-
compromised mice are protected from obesity-induced insulin
resistance. However, it is unanswered whether inﬂammation
triggers systemic insulin resistance or vice versa in obesity. The
purpose of this study was to assess these questions.
RESEARCH DESIGN AND METHODS—We fed a high-fat diet
(HFD) to wild-type mice and three different immuno-compromised
mouse models (lymphocyte-deﬁcient Rag1 knockout, macrophage-
depleted, and hematopoietic cell-speciﬁc Jun NH2-terminal kinase–
deﬁcient mice) and measured the time course of changes in
macrophage content, inﬂammatory markers, and lipid accumu-
lation in adipose tissue, liver, and skeletal muscle along with
systemic insulin sensitivity.
RESULTS—In wild-type mice, body weight and adipose tissue
mass, as well as insulin resistance, were clearly increased by
3 days of HFD. Concurrently, in the short-term HFD period in-
ﬂammation was selectively elevated in adipose tissue. Interest-
ingly, however, all three immuno-compromised mouse models
were not protected from insulin resistance induced by the short-
term HFD. On the other hand, lipid content was markedly
increased in liver and skeletal muscle at day 3 of HFD.
CONCLUSIONS—These data suggest that the initial stage of
HFD-induced insulin resistance is independent of inﬂammation,
whereas the more chronic state of insulin resistance in estab-
lished obesity is largely mediated by macrophage-induced proin-
ﬂammatory actions. The early onset insulin resistance during
HFD feeding is more likely related to acute tissue lipid overload.
Chronic tissue inﬂammation is an important causeof insulin resistance in obesity. A number ofstudies have demonstrated increased accumu-lation of adipose tissue macrophages (ATMs)
in obese humans and rodents (1,2), and it is likely that
macrophage-induced proinﬂammatory signaling is a key
mediator of obesity-induced tissue inﬂammation. It has
also been shown that a speciﬁc subpopulation of CD11c+,
M1-like macrophages account for the majority of the in-
creased ATM content and these macrophages secrete a
variety of cytokines that cause decreased insulin sensi-
tivity through both paracrine and endocrine mechanisms
(3–5). A number of additional studies have shown that
genetic deletion of macrophage inﬂammatory pathway
components has a marked effect to protect against obesity-
induced insulin resistance and glucose intolerance (6–8).
In addition to this inﬂammatory mechanism, it is also
known that lipid overload can cause insulin resistance.
Thus, acute administration of lipid infusions to humans
and rodents rapidly causes decreased insulin sensitivity
through mechanisms that still remain to be completely
deﬁned (9–11). In addition, insulin-resistant adipose tissue
displays enhanced rates of lipolysis and the increased cir-
culating free fatty acid (FFA) levels can cause decreased
insulin sensitivity through a process called lipotoxicity (12).
However, in obesity, the relative roles of inﬂammation and
lipotoxicity as causes of insulin resistance remain to be fully
deﬁned.
Here, we have conducted detailed high-fat diet (HFD)
time course studies in wild-type and immuno-compromised
mouse models, such as macrophage- or lymphocyte-depleted
mice, or hematopoietic cell-speciﬁc Jun NH2-terminal ki-
nase (JNK)–deﬁcient mice, to assess whether inﬂammation
triggers systemic insulin resistance or vice versa in obesity.
RESEARCH DESIGN AND METHODS
Animals and treatments. Seven-week-old male C57BL/6J mice were obtained
fromDaehan-Biolink (Korea) or Jackson Laboratory andwere housed in colony
cages in 12-h light/12-h dark cycles. Rag1 knockout (KO) mice were purchased
from Jackson Laboratory. After a minimum 1 week stabilization period, mice
(8 weeks old) were fed normal chow diet (NCD) until they were subjected to
60% HFD for the indicated time periods (Research Diets, Inc.). Thus, on the day
of death, all of the HFDmice were compared with age-matched chow-fed mice.
The average initial body weights in each group of mice were not different. For
oral glucose tolerance test, the mice were fasted for 6 h and basal blood
samples were taken, followed by oral glucose injection (1 g/kg). Blood samples
were drawn at 10, 20, 30, 45, 60, 90, and 120 min after injection. Mouse clamp
experiments were performed as described previously (13). Insulin-stimulated
glucose disposal rate (ISGDR) was calculated as: ISGDR = glucose disposal
rate (GDR; during the clamp) 2 basal GDR. Therefore, this value represents
a measurement of the increase in GDR from the basal value (basal hepatic
glucose production [HGP] = basal GDR = basal Ra) as a result of the insulin
infused in the clamp. Because basal GDR is the same as basal HGP, the
equation could also be ISGDR = GDR (during the clamp) 2 basal HGP. We
calculated the total GDR during the clamp in the traditional way as glucose
infusion rate (GIR) + HGP (during the clamp). During the clamps, insulin was
infused at a constant rate of 8.0 mU/kg/min. For the clodronate experiments,
liposome-encapsulated clodronate (100 mg/kg) was intraperitoneally injected
into the mice 3 days before the onset of HFD (as a single injection), which was
followed by the second and third injections every 3 days (14). Homeostasis
model assessment of insulin resistance was calculated using the following
formula: fasting glucose (mg/dL) 3 fasting insulin (mU/L)/405. Hematopoietic
cell-speciﬁc JNK-deﬁcient mice were generated as described previously (6).
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All animal procedures were in accordance with the research guidelines for the
use of laboratory animals of Seoul National University and the University of
California San Diego.
Flow cytometry analysis. Fluorescence-activated cell sorter analysis (FACS)
of stromal vascular cells (SVCs) was performed as described previously (15,16).
Epididymal adipose tissue were weighed, rinsed three times in PBS, and then
minced in FACS buffer (PBS supplemented with 1% low endotoxin BSA). Tissue
suspensions were centrifuged at 500 g for 5 min and then collagenase-treated
(1 mg/mL; Sigma-Aldrich) for 30 min at 37°C with shaking. Cell suspensions
were ﬁltered through a 100 mm mesh and centrifuged at 500 g for 5 min. SVC
pellets were then incubated with erythrocyte lysis buffer (ebioscience) for
5 min before centrifuge (300 g; 5 min) and resuspended in FACS buffer. SVCs
were incubated with Fc block for 20 min at 4°C before staining with ﬂuores-
cence labeled primary antibodies or control IgGs for 30 min at 4°C. F4/80-APC
FACS antibody was purchased from AbD Serotec (Raleigh, NC); CD11b-
ﬂuorescein isothiocyanate and CD11c-PE FACS antibodies were from BD
Biosciences. Cells were gently washed twice and resuspended in FACS buffer
with propidium iodide (Sigma-Aldrich). For Foxp3 staining (ebioscience),
SVCs were ﬁxed with Foxp3 staining buffer (ebioscience). After incubation for
5 min at 4°C, cells were washed and then incubated with the ﬂuorescein
isothiocyanate-Foxp3 antibody for 30 min at 4°C. SVCs were analyzed using
a FACS Aria ﬂow cytometer (BD Biosciences). Unstained, single stains and
Fluorescence Minus One controls were used for setting compensation and
gates. The events are ﬁrst gated based on forward versus side scatter area, as
well as side scatter height versus width for a total of three dual parameter
plots to gate out aggregates and debris. We used single color controls to
calculate compensation using the FACSDiva software. A plot of forward
scatter versus PI ﬂuorescence was used as the fourth gate to identify in-
dividual, live cells. To measure markers with the maximum sensitivity, each
ﬂuorochrome was plotted versus PI and polygons were drawn, angled with the
aid of the Fluorescence Minus One controls. This excluded dead and auto-
ﬂuorescent cells, but included dim positives. By using polygon gates in com-
bination with logical gates, inclusion of false-positive cells in the gates was
reduced.
Glucose uptake assay. Glucose uptake assays were performed as described
previously (17).
Macrophage migration assays. Migration of macrophages was measured
using Transwell plates (Corning) with a pore size of 8.0 mm. Raw264.7 mac-
rophages were loaded on a top plate. After 3 h, the cells were washed with
Dulbecco’s modiﬁed Eagle’s medium supplemented with 0.2% BSA, and the
Transwells were transferred to new plates with different adipocyte condi-
tioned media (ACM). Wells were removed, and the cells on the top of the
insert or the bottom were scraped and counted by a hematocytometer. The
migration rate (%) is the percentage of cells in the bottom versus the total cells
in both the bottom and the top. For preparation of ACM, primary adipocytes
from lean control or 3-day HFD-treated mice were incubated in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 0.2% BSA for 12 h.
Whole-mount immunohistochemistry.Whole-mount immunohistochemistry
was performed as described previously (18).
Lipid content measurement. Levels of lipid contents in liver and skeletal
muscle of NCD or HFD mice were measured as described previously (19).
Statistics. The results are shown as means6 SEM. All statistical analysis was
performed by Student t test or ANOVA in Excel (Microsoft); P , 0.05 was
considered signiﬁcant.
RESULTS
Effect of short-term HFD on body weight, fat pad
mass, and adipocyte size. To determine the temporal
transition point when adipose dysfunction begins, C57BL/6J
mice were fed a 60% HFD for 3 days and 1, 2, 5, and 10
weeks, and body weight, epididymal adipose tissue mass,
and adipocyte size were measured at each time point. At
the day of death, all mice were the same age (18 weeks
old) in both NCD and HFD groups. Body weight, epididymal
adipose tissue mass, and adipocyte size were signiﬁcantly
increased after only 3 days of HFD, and these changes
progressed thereafter (Fig. 1). Interestingly, during the ﬁrst
3 to 4 days of HFD, mice consumed ;30% more food (data
not shown) than before or 1 week after HFD regimen,
leading to an abrupt increase of body weight during this
period, which subsides to a lower rate of increase there-
after. In adipose tissue, the expression of genes involved in
lipid storage such as SREBP1, FAS, PPAR-g, LXR-a, and
perilipin were greatly promoted at 3 days of HFD (Sup-
plementary Fig. 1).
Time course of glucose intolerance and insulin re-
sistance on HFD. To examine whether the increased body
weight and adipose tissue mass induced by short-term HFD
were associated with systemic insulin resistance, we per-
formed glucose tolerance tests. Mice fed HFD for only
3 days showed signiﬁcantly impaired glucose tolerance
comparable with that after 10 weeks of HFD (Fig. 2A).
Plasma insulin levels were also elevated by 3 days of HFD
(Fig. 2B), further indicating the onset of systemic insulin
resistance.
To gain better insight into the in vivo effects of short-
term HFD, we performed hyperinsulinemic-euglycemic
clamp studies. Basal glucose levels began to rise as early
as 3 days of HFD (Fig. 2C), and this was accompanied by
an increase in basal HGP rates (Fig. 2D). These results are
consistent with the view that increased basal HGP is the
key determinant of basal hyperglycemia. In contrast, the
GIR progressively fell, beginning at 3 days with a maximal
decrement at 10 weeks of HFD (Fig. 2E), demonstrating
the onset and progression of systemic insulin resistance.
This was accompanied by a gradual decline in ISGDR
(Fig. 2F) and an impaired ability of insulin to suppress
HGP (Fig. 2G; Supplementary Fig. 2) and circulating FFA
levels (Fig. 2H). These in vivo data strongly demonstrate
that 3 days of HFD is sufﬁcient to cause decreased insulin
sensitivity in muscle, liver, and fat and that the magnitude of
the insulin resistance worsens through 10 weeks. It is also
evident that the time of onset of insulin resistance and its
incremental progression over 10 weeks is comparable in the
three major insulin target tissues, liver, muscle, and fat, as
indicated by the similar rate of decline in percent HGP
suppression, ISGDR, and percent FFA suppression, re-
spectively.
It is well established that adipose tissue dysfunction can
contribute to systemic insulin resistance by modulating
insulin action in liver and muscle through secreted adipo-
cytokines. To assess this, we measured circulating levels of
adiponectin, interleukin (IL)-6, and tumor necrosis factor
(TNF)-a. Plasma levels of adiponectin decreased, whereas
plasma IL-6 and TNF-a concentrations were increased at
3 days of HFD (Supplementary Fig. 2), without further
changes by 10 weeks. These results suggest that rapid
dysregulation of adipocytokine production might contribute
to the systemic insulin resistance upon short-term HFD.
Effects on adipose tissue inﬂammation. Adipose tissue
inﬂammation involves increased ATM content with polar-
ization of ATMs into a proinﬂammatory phenotype, often
referred to as M1-like polarization in which ATMs express
high levels of CD11c as well as F4/80 and CD11b (3). As
shown in Fig. 3A, ﬂow cytometry analyses revealed that the
total number of F4/80 and CD11b double-positive ATMs
were elevated in adipose tissue by 3 days of HFD (i), and
a large proportion of these macrophages also expressed
CD11c (triply positive, F4/80+, CD11b+, and CD11c+ proin-
ﬂammatory M1 ATMs; ii). This increase in CD11c-positive
ATM content was also present when data were normalized
to total epididymal adipose tissue mass, or total SVC num-
ber (%SVCs), showing that proinﬂammatory macrophages
accumulate in adipose tissue shortly after HFD (data not
shown). Furthermore, the ratio of CD11c-positive ATMs to
total ATMs was increased at 3 days of HFD (Fig. 3A, iii).
On the other hand, the number of CD11c-negative ATMs
(F4/80+/CD11b+/CD11c2) (%SVCs) was not increased by
3 day-HFD (data not shown), although the total number of
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CD11c-negative ATMs increased (Fig. 3A, iv). Therefore,
these results indicate that the proinﬂammatory M1 polar-
ization of ATMs occurs concomitantly with increased ATM
content.
Regulatory T cells (Tregs) are an anti-inﬂammatory im-
mune cell type and the total number of Tregs was not
changed after HFD (Fig. 3A, v). However, the ratio of Tregs
to the total number of SVCs (data not shown) or to the total
number of CD11c-positive macrophages (Fig. 3A, vi) was
decreased at 3 days of HFD, remaining equally reduced
through 10 weeks. This was because of the increase in
ATMs with no absolute change in Treg numbers. Consistent
with these FACS data, two-dimensional (parafﬁn-section;
Fig. 3B) and three-dimensional (whole-mount; Fig. 3C) im-
munohistochemistry analyses also showed an increase in
ATMs by 3 days of HFD.
To determine whether these changes in ATM content
during short-term HFD are associated with increased in-
ﬂammatory gene expression, we assessed mRNA levels of
proinﬂammatory genes by quantitative RT-PCR. As illus-
trated in Fig. 4 and Supplementary Fig. 3, proinﬂammatory
gene expression was selectively augmented in white adi-
pose tissue after 3 to 7 days of HFD. The increase in pro-
inﬂammatory gene expression was detected in both the
adipocyte and SVC fractions (Supplementary Fig. 3), although
the quantitative changes were much greater in the SVCs.
Macrophage chemotaxis. To test whether increased
ATM content is associated with increased adipocyte che-
moattractant activity, we isolated primary adipocytes from
lean control and 3 day and 7 day HFD-treated mice and
collected ACM from each group. Raw264.7 macrophages
were then incubated with ACM in Transwell plates to
measure chemotaxis activity. As shown in Fig. 5A, mac-
rophage migration was signiﬁcantly increased with ACM
prepared from HFD-treated mice compared with ACM
from control chow-fed mice. Consistent with this, mono-
cyte chemoattractant protein (MCP)-1 expression and se-
cretion from primary adipocytes from HFD mice were
signiﬁcantly increased (Fig. 5B and C). In adipose tissue,
interestingly, whereas HFD led to a large increase in MCP-
1 expression in adipocytes, the expression of MCP-1 in the
SVC fraction was unchanged at the end of the 7-day HFD
period (Supplementary Fig. 3). In contrast, TNF-a and IL-6
expression was predominantly from SVCs, not adipocytes
(Supplementary Fig. 3). These data indicate that enhanced
macrophage inﬁltration into adipose tissue after short-term
HFD is a result of increased adipocyte-derived chemo-
attractive activity.
FIG. 1. In 3 days of HFD, body weight, fat mass, and adipocyte size are increased signiﬁcantly. Eight-week-old C57BL6J male mice were fed NCD
until they were subjected to 60% HFD. HFD was treated to the mice 0 (NCD), 3 days (3 D), 1 week (1 W), 2 weeks (2 W), 5 weeks (5 W), or 10
weeks (10 W) before death. At the age of 18 weeks, all mice were killed and subjected to several analyses. A: Body weight of the mice at the end of
the experiment. n = 8 at each time point. Increase of body weight started to be observed by 3 days of HFD. Body weight of mice with 5-week HFD
and 10-week HFD was not signiﬁcantly different. B: Epididymal (Epid.) fat mass. n = 8 at each time point. C: Histology analysis of epididymal
adipose tissue. The epididymal adipose tissues were subjected to hematoxylin-eosin staining. n = 4 at each time point. D and E: Further qualitative
changes of adipocyte size and morphology by short-term HFD were assessed by histology analysis of whole-mount epididymal adipose tissue.
D: BODIPY staining of whole-mount adipose tissue from the mice treated with NCD or HFD. Adipocyte size was markedly increased by 3 days of
HFD. n = 6. Signal intensity of BODIPY staining was adjusted for optimal measurement of adipocyte size using ImageJ software. E: Distribution of
adipocyte size in epididymal adipose tissue from mice treated with NCD or HFD. (A high-quality digital representation of this ﬁgure is available in
the online issue.)
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Lymphocytes are not necessary for short-term HFD-
induced insulin resistance. To examine the potential
role of lymphocytes in the systemic insulin resistance and
adipose tissue inﬂammation induced by short-term HFD,
we used lymphocyte-deﬁcient Rag1 KO mice. Consistent
with previous reports (20), NCD-fed Rag1 KO mice showed
higher levels of basal ATM inﬁltration and M1 polarization
than those of wild-type mice (Fig. 6A). After 1 week of
HFD, a signiﬁcant increase in ATM inﬁltration and M1
polarization was observed in Rag1 KO mice along with
increased fat mass and inﬂammatory gene expression
(Fig. 6A–C). Additionally, Rag1 KO mice developed glu-
cose intolerance as early as 3 days of HFD with increased
blood insulin levels (Fig. 6D and E). Moreover, insulin
tolerance tests indicated that Rag1 KO mice exhibited
a similar level of insulin resistance as wild-type mice by 1
week HFD (Fig. 6F). In vitro glucose uptake assays
showed that primary adipocytes from 1 week HFD-fed
Rag1 KO mice were insulin resistant (Fig. 6G). Together,
these results suggest that lymphocytes are not necessary
for short-term HFD-induced adipose dysfunction and in-
sulin resistance.
FIG. 2. HFD induces systemic insulin resistance in 3 days. A: C57BL/6J male mice were treated with NCD or HFD and subjected to oral glucose
(Glc) tolerance test. n = 8 at each time point. ***P < 0.001 NCD vs. 3-day HFD. B: Blood insulin levels at time 0 and 10 min after glucose injection.
Basal insulin level was signiﬁcantly elevated by 3 days of HFD and then further increase was detected signiﬁcantly by 5 and 10 weeks of HFD. n = 8.
*P< 0.05 NCD vs. 3-day HFD; ***P< 0.001 NCD vs. 3-day HFD; †P< 0.05 3-day HFD vs. 10-week HFD; ††P< 0.01 3-day HFD vs. 10-week HFD. C–H:
Hyperinsulinemic euglycemic clamp was performed in mice treated with HFD for different periods; n = 8 (NCD, and 3-day and 1-week HFD mice) or
n = 6 (10-week HFD mice). C: Basal blood glucose level (before clamp). **P < 0.01. D: Basal hepatic glucose production. *P < 0.05; **P < 0.01.
E: GIR. **P < 0.01. F: ISGDR. **P < 0.01. G: Insulin-dependent suppression of hepatic glucose. **P < 0.01. H: Suppression of plasma FFA level by
insulin. *P < 0.05; **P < 0.01.
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Macrophages are not critical for short-term HFD-
induced insulin resistance. To determine whether mac-
rophages are essential for the initiation of HFD-induced
insulin resistance, we tested the effect of clodronate-
mediated depletion of macrophages on insulin sensitivity
in 3 day HFD-fed mice. After clodronate injection (48 h),
ATMs were depleted by 80%, and this effect was sustained
for up to 3 days (Fig. 7A). Under the same conditions,
there were no detectable changes in adipocyte size or
morphology (Fig. 7B). Despite that, serum levels of pro-
inﬂammatory cytokines such as IL-6 and TNF-a were sig-
niﬁcantly decreased by clodronate (Fig. 7C). Interestingly,
glucose uptake assays in primary adipocytes revealed that
clodronate-mediated depletion of macrophages did not re-
store the HFD-induced decrease in insulin-stimulated glu-
cose uptake (Fig. 7D). Moreover, clodronate treatment did
not improve glucose tolerance or insulin resistance in mice
fed HFD for 3 or 7 days (Fig. 7E–G). Because clodronate
FIG. 3. Macrophage inﬁltration and polarization increase in 3 days of HFD. Mice were treated with NCD (N) or HFD for a series of periods as
indicated: 3D, 3 days; 2W, 2 weeks; 10W, 10 weeks. After 10 weeks from when ﬁrst mice were fed HFD, mice were killed and epididymal adipose
tissues were taken for further analyses. A: Flow cytometry analyses of immune cells in stromal vascular fraction of adipose tissue. #P< 0.05; ##P<
0.01; n = 4 (NCD and 2-week HFD mice) or n = 6 (1-week and 10-week HFD mice). B: Immunohistochemistry analysis of epididymal adipose tissue.
The epididymal adipose tissues were stained with antibodies against MAC2 and then subjected to hematoxylin-eosin staining. n = 4. C: Whole-
mount immunohistochemistry analysis of epididymal adipose tissue from NCD, or 3 or 7 days HFD-treated mice. Samples were stained with DAPI
(blue) or antibodies against CD11b (red) and CD11c (green) and visualized by multiphoton confocal microscopy. Scale bar denotes 50 mm. (A high-
quality digital representation of this ﬁgure is available in the online issue.)
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targets all phagocytic cell populations, including hepatic
Kupffer cells (Supplementary Fig. 4), we also tested the
Kupffer cell inhibitor, gadolinium. Similar to clodronate,
gadolinium did not affect 1 week HFD-induced glucose
intolerance (Supplementary Fig. 5). In marked contrast,
both clodronate and gadolinium signiﬁcantly improved
glucose tolerance in long-term (14 week) HFD-treated mice
(Supplementary Fig. 6) or obese/diabetic db/db mice (data
not shown). These results are consistent with our previous
report that depletion of proinﬂammatory macrophages
readily reverses the insulin resistance in well-established
obesity (7). Thus, these data suggest that ATMs and Kupffer
cells do not play a critical role in the insulin resistance
caused by short-term HFD but are essential for the devel-
opment of insulin resistance after long-term (14 weeks) HFD.
To assess this concept with an alternative approach,
we determined the effect of suppressing proinﬂammatory
activity in immune cells using hematopoietic cell-speciﬁc
JNK-deﬁcient mice. Previously, we have shown that he-
matopoietic cell-speciﬁc JNK deﬁciency protects mice
from long-term HFD-induced insulin resistance (6). As
shown in Fig. 7H–J, hematopoietic cell-speciﬁc JNK de-
ﬁciency did not ameliorate short-term HFD-induced insulin
resistance. These results are consistent with the idea that
macrophage-mediated inﬂammation is necessary for the
insulin resistance associated with long-term HFD/obesity,
but not as a result of short-term HFD.
Ceramide accumulates in liver and muscle acutely
after HFD. A number of studies have shown that insulin
resistance in obesity is associated with activation of in-
tracellular diacylglycerol (DAG)/protein kinase C (PKC)u
and ceramide pathways (10,21). To determine whether
lipid overload as a result of short-term HFD is associated
with systemic insulin resistance, we measured various
lipid components in liver and skeletal muscle of NCD mice
and after 3 days and 5 weeks of HFD. As shown in Fig. 8,
levels of triacylglycerol, nonesteriﬁed fatty acids (NEFA),
DAG, and ceramide were all signiﬁcantly increased in liver
and skeletal muscle by 3 days of HFD. Of interest, clodr-
onate treatment did not affect short-term HFD–induced
accumulation of DAG, ceramide, and NEFA in liver and
skeletal muscle, whereas it blunted triacylglycerol content
(Fig. 8).
FIG. 4. Inﬂammatory gene expression is induced in 3 days after HFD. C57BL/6J mice were treated with HFD. Mice were fed HFD for 0 (0 or N),
1 (1), 3 (3), or 7 days (7), or 16 weeks (H). mRNA levels of inﬂammatory genes from epididymal adipose tissue (WAT), brown adipose tissue
(BAT), liver, and skeletal muscle were measured by quantitative real-time RT-PCR analysis. n = 10 at each time point. *P< 0.05; **P< 0.01; ***P<
0.001. iNOS, inducible nitric oxide synthase.
FIG. 5. Adipocytes become more chemoattractive to macrophages after
3 days of HFD. A: Macrophage migration assays using primary ACM
from mice treated with NCD or HFD. ACM were obtained by incubating
mouse primary adipocytes in serum-free Dulbecco’s modiﬁed Eagle’s
medium for 12 h. 3d, 3 days; 1w, 1 week. B: MCP-1 protein expression
from the primary adipocytes. C: MCP-1 protein secretion from those
adipocytes.
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DISCUSSION
Here, we have evaluated the in vitro and in vivo initiation
and progression of inﬂammation and insulin resistance
during the development of obesity in HFD-fed mice. Be-
cause of the temporal nature of this study, we were able to
assess the causes of insulin resistance in the early stages
of HFD-induced obesity, as well as later on in this process
after obesity was well established. We found that glucose
intolerance and systemic insulin resistance developed by
3 days of HFD. The systemic insulin resistance steadily
FIG. 6. Rag1 KO mice develop insulin resistance with increased macrophage activation in 1 week of HFD. A: Macrophage inﬁltration and M1
polarization were increased by short-term HFD. Rag1 KO mice were treated with HFD for 1 week and killed, and epididymal adipose tissues were
taken for further analyses. Total macrophages (double positive; F4/80+, CD11b+) and CD11c positive macrophages (triple positive cells; F4/80+,
CD11b+, CD11c+) were increased in adipose tissue in 1 week of HFD. *P < 0.05 KO-NCD vs. KO HFD; ***P < 0.001 KO-NCD vs. KO HFD; #P < 0.05
wild-type (WT)-NCD vs. WT HFD; ##P < 0.01 WT-NCD vs. WT HFD. n = 6. B: Epididymal adipose tissue mass in NCD and 1-week HFD treated Rag1
KO mice. C: Expression of inﬂammatory genes was promoted in 1-week HFD-fed Rag1 KO mice. mRNA levels of inﬂammatory genes from epi-
didymal adipose tissue were measured by quantitative real-time RT-PCR analysis. D–F: HFD rapidly induces systemic insulin resistance in Rag1 KO
mice. D: Rag1 KO mice (8 weeks old, male) were treated with NCD or HFD for 3 days (i) or 1 week (ii) and subjected to oral glucose tolerance test.
E: Serum insulin levels of Rag1 KO mice treated with NCD or HFD (for 1 week) during oral glucose tolerance. 0 min, before glucose injection;
10 min, 10 min after glucose injection. F: WT or Rag1 KO mice were treated with NCD or HFD for 1 week and subjected to insulin tolerance test.
G: Glucose-uptake assays using primary adipocytes from mice treated with NCD or HFD for 1 week. ***P < 0.001.
Y.S. LEE AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES 7
worsened with increasing adipose tissue inﬂammation, and
the temporal sequence and magnitude of initiation and
progression of decreased insulin sensitivity was compa-
rable in muscle, adipose tissue, and liver. Concurrently, a
variety of markers of inﬂammation can be readily detected
in adipose tissue, by as early as 3 days, and progressively
increased throughout the 10-week HFD feeding period.
However, in liver and skeletal muscle, increased inﬂam-
mation became apparent only after several weeks into the
HFD period, after obesity was well established (Fig. 4).
Furthermore, depletion of macrophages or Kupffer cells
by clodronate-liposomes or gadolinium administration or
disruption of macrophage inﬂammatory pathways by JNK1
deletion did not attenuate the early stage of insulin re-
sistance (Fig. 7 and Supplementary Fig. 5). In contrast,
these maneuvers substantially ameliorated insulin resis-
tance at 14 weeks of HFD, at a time when severe obesity
was established (Supplementary Fig. 6). Thus, our data
suggest that macrophage-mediated tissue inﬂammation is
a key component of chronic obesity–associated insulin re-
sistance but is not critical for the decrease in insulin sen-
sitivity, which develops at the early stage of HFD feeding.
FIG. 7. Macrophage depletion using clodronate-liposomes does not affect short-term HFD–dependent adipocyte insulin resistance. Mice were treated
with NCD or 60% HFD in the presence or absence of clodronate injection. Mice were given clodronate injection (100 mg/kg i.p.) 3 days before HFD,
which was followed by a second and third injection every 3 days (at days 0 and 3). A: Flow cytometry analysis of CD11c-positive macrophages in
adipose tissue. V, vehicle (empty liposomes); C, clodronate-liposomes. B: Whole-mount immunohistochemistry analysis of epididymal adipose tissue.
Veh, vehicle; Clod, clodronate-liposomes. C: Cytokine concentration in the mouse sera injected with vehicle and clodronate. *P < 0.05. D: Glucose-
uptake assays using primary adipocytes from mice treated with NCD or HFD for 1 week with or without clodronate injection. White columns denote
relative glucose uptake activity without insulin. Black columns denote relative glucose uptake activity with insulin. Cld, clodronate-liposomes. E:
Oral glucose tolerance test (OGTT) of mice treated with HFD for 3 days. #P< 0.05 Veh-NCD vs. Veh-HFD; *P< 0.05 Cld-NCD vs. Cld-HFD; **P< 0.01
Cld-NCD vs. Cld-HFD; ***P< 0.001 Cld-NCD vs. Cld-HFD. n = 6. F: Glucose tolerance test of mice treated with HFD for 7 days. #P< 0.05 Veh-NCD vs.
Veh-HFD; ##P < 0.01 Veh-NCD vs. Veh-HFD; ###P < 0.001 Veh-NCD vs. Veh-HFD; *P < 0.05 Cld-NCD vs. Cld-HFD; **P < 0.01 Cld-NCD vs. Cld-HFD.
n = 6. G: Homeostasis model assessment of insulin resistance. H–J: Hematopoietic cell-speciﬁc JNK deﬁciency does not affect short-term HFD-in-
duced insulin resistance. For the generation of radiation chimera, C57BL/6J mice received a lethal dose of 10 Gy of ionizing radiation, followed by tail
vein injection of 107 bone marrow cells either from wild-type (WT) or JNK KO mice. After 6 weeks of bone marrow reconstitution, mice were
subjected to 3 or 7 days of HFD, followed by hyperinsulinemic euglycemic clamp. n = 4 to 5. H: GIR. I: ISGDR. J: Insulin-dependent hepatic glucose
suppression. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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Our data indicate that the inﬂammation elicited by short
term HFD was not sufﬁcient to induce insulin resistance.
Although elevation of inﬂammatory gene expression in ad-
ipose tissue and macrophage inﬁltration were signiﬁcant at
3 days of HFD, the fold of increase by 3 or 7 days of HFD
was much lower than that observed by 16 weeks of HFD
(Fig. 4). Moreover, inﬂammation in muscle and liver was
not observed during short-term HFD, in contrast with long-
term 16 week HFD, suggesting that inﬂammation initiated in
adipose tissue by short-term HFD was not able to propagate
to other tissues as to induce insulin resistance.
Within the ﬁrst several days of HFD, changes in circu-
lating adipocytokine concentrations were observed (de-
creased adiponectin, increased TNF-a, and IL-6), which
could contribute to decreased systemic insulin sensitivity,
suggesting that acute induction of adipose tissue dysfunc-
tion might play important roles in short-term HFD–induced
systemic insulin resistance. However, it is interesting to
note that although insulin resistance progressively wors-
ened from 3 days to 10 weeks, no further changes in adi-
pocytokine levels were detected, indicating that some other
mechanism must be responsible for the steady progression
of the degree of insulin resistance. The chronic tissue in-
ﬂammatory state is an excellent candidate for this mecha-
nism, since accumulation of proinﬂammatory macrophages
in adipose tissue gradually increased throughout the 10-
week study period, and the increase in ATMs correlated
very well with the magnitude of the insulin resistance
(Fig. 4). Furthermore, increased inﬂammation in muscle
and liver was only detected in the latter stages of HFD, as
systemic insulin resistance worsened. Thus, chronic tis-
sue inﬂammation is at least one major cause of systemic
insulin resistance associated with the obese state.
A possible mechanism for the early phase of insulin re-
sistance seems to also relate to the lipid overload observed
at the onset of HFD. It has been shown that intravenous
lipid infusions rapidly cause systemic insulin resistance in
humans and mice (9,11,21–25) and that this can be blunted
by genetic ablation of PKCu (10). This is associated with
increased cellular levels of DAGs, ceramides, and other
lipid-derived molecules, and this process of lipid-induced
insulin resistance is termed lipotoxicity. Indeed, we ob-
served that ceramide, DAG, and NEFA levels were in-
creased in muscle and liver by 3 days of HFD and were not
affected by clodronate treatment (Fig. 8). Thus, it seems
possible that the large excess lipid intake at the onset of
HFD would trigger decreased insulin sensitivity through an
acute lipotoxic mechanism, whereas chronic tissue in-
ﬂammation emerges as a key cause of insulin resistance
during the established stage of obesity. It is of interest that
the timing of the onset and the progressive worsening of
the insulin resistance is comparable across the three major
insulin target tissues, muscle, liver, and fat, despite the fact
that the underlying mechanisms evolve during transition
from the early to the later stages of HFD feeding and de-
velopment of obesity.
Glucose intolerance, as well as increased HGP, was ob-
served by 3 days of HFD and did not worsen throughout
the next 10 weeks; i.e., these changes were nonprogressive.
In contrast, although insulin resistance was readily detected
by 3 days of HFD, it was progressively more severe by
1 week and then even more so by 10 weeks. This raises
the question as to why glucose intolerance does not worsen
with the progression of insulin resistance. A likely reason
relates to the circulating insulin levels. Insulin levels are
substantially higher at the later stages of HFD, compared
with the earlier time points (Fig. 2B). This indicates that
progressive hyperinsulinemia, most likely as a result of in-
creasing b-cell hyperplasia (data not shown), increases over
the later stages of HFD, compensating for the worsening
insulin resistance state. However, this compensation does
not reregulate glucose tolerance to normal but maintains
glucose tolerance at the same level as observed during the
initial 3-day HFD time point.
Recently, it has been found that adipose inﬂammation
and increased ATM inﬁltration in obesity is accompanied
by changes in subpopulations of T cells such as Tregs and
CD8-positive T cells residing in adipose tissue (26,27). We
observed that the total number of Tregs in the epididymal
adipose tissue was not decreased at any point during the
10-week HFD period, whereas the ratio of Tregs to the other
cell types in SVCs, especially to M1-like macrophages,
FIG. 8. Lipid contents of liver and skeletal muscle after 3 days of HFD. Eighteen-week-old C57BL6J male chow-fed mice were started in 60% HFD
at day 0 for 3 days before the analyses. A separate group of age-matched chow-fed mice was studied as controls. For the macrophage depletion
experiment, two shots of clodronate injection (100 mg/kg i.p.) were given at day 23 and 0. Veh, vehicle; Clod, clodronate-liposomes. A: Lipid
contents in liver. B: Lipid contents in skeletal muscle. n = 8. *P < 0.05; **P < 0.01. NS, not signiﬁcant.
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decreased signiﬁcantly (Fig. 3A). These results are con-
sistent with the view that passive changes in Treg ratios
in adipose tissue, but not active suppression of Treg in-
ﬁltration or proliferation, can be correlated with adipose
tissue remodeling and ATM accumulation, conferring adi-
pose tissue inﬂammation. Although this relative change in
Treg proportions might contribute to migration or activa-
tion of ATMs, the macrophages would likely still be the
effector cells promoting decreased insulin sensitivity in
obesity. Moreover, lymphocyte-deﬁcient Rag1 KO mice
were not protected from short-term HFD-induced insulin
resistance and glucose intolerance, or ATM accumulation
(Fig. 6). Therefore it is likely that lymphocytes do not
signiﬁcantly contribute to short-term HFD–induced insulin
resistance and adipose tissue inﬂammation.
In summary, we have assessed the temporal events un-
derlying the development of insulin resistance during
high-fat feeding. We found that decreased systemic in-
sulin sensitivity appears early in the course of HFD and
progressively increases at similar rates in muscle, liver,
and adipose tissue. Interestingly, different mechanisms ap-
pear to evolve over the 10-week HFD period; i.e., lipid
overload and lipotoxicity are more important early on,
whereas chronic inﬂammation emerges as a more domi-
nant mechanism once obesity is established toward the
end of the HFD period.
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